Prelude Capital Management’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $214K | Buy |
64,702
+16,361
| +34% | +$54.2K | 0.02% | 781 |
|
|
2025
Q1 | $140K | Buy |
48,341
+36,409
| +305% | +$106K | 0.01% | 908 |
|
|
2024
Q4 | $42.5K | Sell |
11,932
-4,576
| -28% | -$16.3K | ﹤0.01% | 1023 |
|
|
2024
Q3 | $82.2K | Sell |
16,508
-71,882
| -81% | -$358K | 0.01% | 1073 |
|
|
2024
Q2 | $230K | Buy |
88,390
+63,594
| +256% | +$165K | 0.02% | 836 |
|
|
2024
Q1 | $106K | Buy |
+24,796
| New | +$106K | 0.01% | 1083 |
|
|
2019
Q1 | – | Sell |
-201
| Closed | -$1K | – | 1340 |
|
|
2018
Q4 | $1K | Buy |
+201
| New | +$1K | ﹤0.01% | 1330 |
|